Combined chloroquine and ribavirin treatment does not prevent death in a hamster model of Nipah and Hendra virus infection.
about
A systematic screen of FDA-approved drugs for inhibitors of biological threat agentsHenipavirus mediated membrane fusion, virus entry and targeted therapeuticsChloroquine inhibited Ebola virus replication in vitro but failed to protect against infection and disease in the in vivo guinea pig modelChemoprophylaxis of Tropical Infectious Diseases.Off Label Antiviral Therapeutics for Henipaviruses: New Light Through Old Windows.A novel model of lethal Hendra virus infection in African green monkeys and the effectiveness of ribavirin treatmentHenipavirus infections: lessons from animal models.Henipavirus outbreaks to antivirals: the current status of potential therapeutics.A treatment for and vaccine against the deadly Hendra and Nipah virusesAntiviral therapies against Ebola and other emerging viral diseases using existing medicines that block virus entry.Hendra and nipah infection: pathology, models and potential therapies.Emerging paramyxoviruses: molecular mechanisms and antiviral strategiesHendra virus: a one health tale of flying foxes, horses and humans.Henipavirus pathogenesis and antiviral approaches.Henipavirus Encephalitis: Recent Developments and Advances.Infection of primary neurons mediated by nipah virus envelope proteins: role of host target cells in antiviral action.Development of a reverse genetics system for Sosuga virus allows rapid screening of antiviral compounds.Favipiravir (T-705) protects against Nipah virus infection in the hamster model.
P2860
Q21559667-CE0577E7-53C3-4BAD-81E8-701052A82F2EQ27002511-F2E4A27E-3F14-4B15-B726-56C27A465905Q33617999-847A6E0E-7514-4140-90DC-61D6CB82B710Q33664324-23069F34-7FC8-433F-8442-C07BABBE2BD8Q34021811-830539FF-7CC0-45BA-83FE-3EE183279458Q34120677-FC19EC67-220C-4DA3-B9A2-643E315BFC4AQ34533606-F4066C8F-CB98-4CB8-9D43-36A24D2ED6EAQ35141580-B14CC36C-1E2A-4B5B-9ECD-DC0840B0422DQ35565878-BFE42C28-104E-4AE3-8127-11CCAF9043CDQ35605579-13936E68-BB7E-442A-BCA0-9D453871A3E8Q35658146-F5429080-8996-4814-A53F-BC7CCA2D5B4DQ35658152-A42368A8-63CF-4920-91F2-60CBE4E3E5D5Q38093644-2239B8A9-3F44-4C65-B399-D7A36DA3A53FQ38337204-F4C0F8A3-1BFA-4E73-846D-49CF1CA5D91AQ38567114-53E0565A-69BE-4055-B1C9-7E12C8432347Q39528697-3C4DEADB-9B89-44A1-A60D-FD9D3276B685Q52664407-748FE849-2A03-4EA9-9234-759FD412F132Q54989893-C2BD472A-4E3F-4871-A807-5FFAAEE551FA
P2860
Combined chloroquine and ribavirin treatment does not prevent death in a hamster model of Nipah and Hendra virus infection.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Combined chloroquine and ribav ...... ah and Hendra virus infection.
@ast
Combined chloroquine and ribav ...... ah and Hendra virus infection.
@en
type
label
Combined chloroquine and ribav ...... ah and Hendra virus infection.
@ast
Combined chloroquine and ribav ...... ah and Hendra virus infection.
@en
altLabel
Combined chloroquine and ribav ...... pah and Hendra virus infection
@en
prefLabel
Combined chloroquine and ribav ...... ah and Hendra virus infection.
@ast
Combined chloroquine and ribav ...... ah and Hendra virus infection.
@en
P2093
P2860
P921
P356
P1476
Combined chloroquine and ribav ...... ah and Hendra virus infection.
@en
P2093
Alexander N Freiberg
Melissa N Worthy
Michael R Holbrook
P2860
P304
P356
10.1099/VIR.0.017269-0
P407
P50
P577
2009-11-04T00:00:00Z